References
Brown IAM, Diederich L, Good ME, DeLalio LJ, Murphy SA, Cortese-Krott MM, et al. (2018). Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension.Arteriosclerosis, thrombosis, and vascular biology 38:1969-1985.
Cai W, Zhang J, Yang J, Fan Z, Liu X, Gao W, et al. (2019). MicroRNA-24 attenuates vascular remodeling in diabetic rats through PI3K/Akt signaling pathway. Nutrition, metabolism, and cardiovascular diseases : NMCD 29: 621-632.
Chen WJ, Chen YH, Hsu YJ, Lin KH, Yeh YH (2018a). MicroRNA-132 targeting PTEN contributes to cilostazol-promoted vascular smooth muscle cell differentiation. Atherosclerosis 274: 1-7.
Chen Z, Wang M, Huang K, He Q, Li H, Chang G (2018b). MicroRNA-125b Affects Vascular Smooth Muscle Cell Function by Targeting Serum Response Factor. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 46: 1566-1580.
Chiang MH, Liang CJ, Lin LC, Yang YF, Huang CC, Chen YH, et al.(2020). miR-26a attenuates cardiac apoptosis and fibrosis by targeting ataxia-telangiectasia mutated in myocardial infarction. Journal of cellular physiology .
Curtis MJ, Alexander S, Cirino G, Docherty JR, George CH, Giembycz MA, et al. (2018). Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. British journal of pharmacology 175: 987-993.
Dai X, Chen C, Yang Q, Xue J, Chen X, Sun B, et al. (2018). Exosomal circRNA_100284 from arsenite-transformed cells, via microRNA-217 regulation of EZH2, is involved in the malignant transformation of human hepatic cells by accelerating the cell cycle and promoting cell proliferation. Cell death & disease 9:454.
Das S, Zhang E, Senapati P, Amaram V, Reddy MA, Stapleton K, et al. (2018). A Novel Angiotensin II-Induced Long Noncoding RNA Giver Regulates Oxidative Stress, Inflammation, and Proliferation in Vascular Smooth Muscle Cells. Circulation research 123:1298-1312.
Deniset JF, Hedley TE, Hlavackova M, Chahine MN, Dibrov E, O’Hara K, et al. (2018). Heat shock protein 60 involvement in vascular smooth muscle cell proliferation. Cellular signalling47: 44-51.
Gul A, Leyland-Jones B, Dey N, De P (2018). A combination of the PI3K pathway inhibitor plus cell cycle pathway inhibitor to combat endocrine resistance in hormone receptor-positive breast cancer: a genomic algorithm-based treatment approach. American journal of cancer research 8: 2359-2376.
Hayashi K, Naiki T (2009). Adaptation and remodeling of vascular wall; biomechanical response to hypertension. Journal of the mechanical behavior of biomedical materials 2: 3-19.
He F, Chu JF, Chen HW, Lin W, Lin S, Chen YQ, et al. (2019). Qingxuan Jiangya Decoction () Prevents Blood Pressure Elevation and Ameliorates Vascular Structural Remodeling via Modulating TGF- beta 1/Smad Pathway in Spontaneously Hypertensive Rats. Chinese journal of integrative medicine .
Henn D, Abu-Halima M, Wermke D, Falkner F, Thomas B, Kopple C, et al. (2019). MicroRNA-regulated pathways of flow-stimulated angiogenesis and vascular remodeling in vivo. Journal of translational medicine 17: 22.
Jiang H, Chen Y, Yu T, Zhao X, Shan H, Sun J, et al. (2018). Inhibition of lncRNA PFRL prevents pulmonary fibrosis by disrupting the miR-26a/smad2 loop. American journal of physiology. Lung cellular and molecular physiology 315: L563-l575.
Karimian A, Ahmadi Y, Yousefi B (2016). Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.DNA repair 42: 63-71.
Krol J, Loedige I, Filipowicz W (2010). The widespread regulation of microRNA biogenesis, function and decay. Nature reviews. Genetics11: 597-610.
Lee TH, Sottile J, Chiang HY (2015). Collagen inhibitory peptide R1R2 mediates vascular remodeling by decreasing inflammation and smooth muscle cell activation. PloS one 10: e0117356.
Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, et al. (2011). MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. Journal of cellular physiology226: 1035-1043.
Lemarie CA, Tharaux PL, Lehoux S (2010). Extracellular matrix alterations in hypertensive vascular remodeling. Journal of molecular and cellular cardiology 48: 433-439.
Li C, Chen X, Huang J, Sun Q, Wang L (2015). Clinical impact of circulating miR-26a, miR-191, and miR-208b in plasma of patients with acute myocardial infarction. European journal of medical research20: 58.
Li C, Zhen G, Chai Y, Xie L, Crane JL, Farber E, et al. (2016). RhoA determines lineage fate of mesenchymal stem cells by modulating CTGF-VEGF complex in extracellular matrix. Nature communications7: 11455.
Li Z, Yu D, Li H, Lv Y, Li S (2019). Long noncoding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway.International journal of oncology 54: 1033-1042.
Liang H, Xu C, Pan Z, Zhang Y, Xu Z, Chen Y, et al. (2014). The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Molecular therapy : the journal of the American Society of Gene Therapy 22: 1122-1133.
Liu J, Li X, Wang M, Xiao G, Yang G, Wang H, et al. (2018). A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer. International journal of oncology53: 1601-1612.
Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, et al. (2011). MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer research71: 225-233.
Lu QB, Wang HP, Tang ZH, Cheng H, Du Q, Wang YB, et al. (2018). Nesfatin-1 functions as a switch for phenotype transformation and proliferation of VSMCs in hypertensive vascular remodeling.Biochimica et biophysica acta. Molecular basis of disease1864: 2154-2168.
Magnussen CG (2017). Carotid artery intima-media thickness and hypertensive heart disease: a short review. Clinical hypertension23: 7.
Mulvany MJ (2012). Small artery remodelling in hypertension. Basic & clinical pharmacology & toxicology 110: 49-55.
Pei Y, Singh RK, Shukla SK, Lang F, Zhang S, Robertson ES (2018). Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2. Journal of virology 92.
Peng J, He X, Zhang L, Liu P (2018). MicroRNA26a protects vascular smooth muscle cells against H2O2induced injury through activation of the PTEN/AKT/mTOR pathway. International journal of molecular medicine 42: 1367-1378.
Petrosino JM, Leask A, Accornero F (2019). Genetic manipulation of CCN2/CTGF unveils cell-specific ECM-remodeling effects in injured skeletal muscle. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 33:2047-2057.
Ricard-Blum S, Vallet SD (2019). Fragments generated upon extracellular matrix remodeling: Biological regulators and potential drugs.Matrix biology : journal of the International Society for Matrix Biology 75-76: 170-189.
Sysol JR, Chen J, Singla S, Zhao S, Comhair S, Natarajan V, et al. (2018). Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1. American journal of physiology. Lung cellular and molecular physiology 314: L461-l472.
Tan J, Yang L, Liu C, Yan Z (2017). MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia. Scientific reports 7: 46602.
Wang D, Atanasov AG (2019a). The microRNAs Regulating Vascular Smooth Muscle Cell Proliferation: A Minireview. International journal of molecular sciences 20.
Wang J, Zhang C, Li C, Zhao D, Li S, Ma L, et al. (2019b). MicroRNA-92a promotes vascular smooth muscle cell proliferation and migration through the ROCK/MLCK signalling pathway. Journal of cellular and molecular medicine 23: 3696-3710.
Wei C, Kim IK, Kumar S, Jayasinghe S, Hong N, Castoldi G, et al.(2013). NF-kappaB mediated miR-26a regulation in cardiac fibrosis.Journal of cellular physiology 228: 1433-1442.
Xu HM, Sui FH, Sun MH, Guo GL (2019). Downregulated microRNA-224 aggravates vulnerable atherosclerotic plaques and vascular remodeling in acute coronary syndrome through activation of the TGF-beta/Smad pathway.Journal of cellular physiology 234: 2537-2551.
Yang X, Niu X, Xiao Y, Lin K, Chen X (2018). MiRNA expression profiles in healthy OSAHS and OSAHS with arterial hypertension: potential diagnostic and early warning markers. Respiratory research19: 194.
Zhang CJ, Shi YN, Liao DF, Du K, Qin L (2019). [Molecular mechanism of vascular remodeling in hypertension and Chinese medicine intervention]. Sheng li xue bao : [Acta physiologica Sinica] 71: 235-247.
Zhang S, Cui R (2018). The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction. European review for medical and pharmacological sciences 22: 523-531.
Zhou J, Ju WQ, Yuan XP, Zhu XF, Wang DP, He XS (2016). miR-26a regulates mouse hepatocyte proliferation via directly targeting the 3’ untranslated region of CCND2 and CCNE2. Hepatobiliary & pancreatic diseases international : HBPD INT 15: 65-72.